Advisory Panel Says FDA Should Not Approve Drug To Address Female Sexual Dysfunction
Links shared publicly online about this topic.
- 1,075total visits
Advisory Panel Says FDA Should Not Approve Drug To Address Female Sexual Dysfunction
On Friday, an FDA advisory panel voted 11-0 against recommending FDA approval of a proposed treatment for hypoactive sexual-desire disorder, which decreases women's sex drive, the
View full resource at medicalnewstoday.com
Tags: Sexual Health, Disease and Condition, Drug, Sex and Intimacy, Women's Health, FDA, Sexual Dysfunction
Most Recently Shared on June 22, 2010 at 9:06 pm By:
Advisory Panel Says FDA Should Not Approve Drug To Address Female Sexual Dysfunction http://mnt.to/3FbY #womenshealth
Also Shared By:
Advertisement
Sexual_HealthOW
@Sexual_HealthOW
Advisory Panel Says FDA Should Not Approve Drug To Address Female Sexual Dysfunction: On Friday, an FDA advisory p... http://mnt.to/f/3FbY
1 year ago...